5">Dusquetide reduces the duration of mucositis in preclinical animal models.
Dusquetide reduces the duration of oral mucositis in a Phase 2a clinical study.
5">Preclinical models of mucositis were highly predictive of clinical results.
Innate immune modulation is a successful strategy for mitigating mucositis.